State of the art in benefit-risk analysis: Consumer perception

被引:64
|
作者
Ueland, O. [1 ]
Gunnlaugsdottir, H. [2 ]
Holm, F. [3 ]
Kalogeras, N. [4 ]
Leino, O. [5 ]
Luteijn, J. M. [6 ]
Magnusson, S. H. [2 ]
Odekerken, G. [4 ]
Pohjola, M. V. [5 ]
Tijhuis, M. J. [4 ,7 ]
Tuomisto, J. T. [5 ]
White, B. C. [8 ]
Verhagen, H. [7 ,9 ,10 ]
机构
[1] Nofima, N-1430 As, Norway
[2] Matis, Iceland Food & Biotech R&D, IS Reykjavik 113, Iceland
[3] FoodGrp Denmark & Nord NutriSci, DK-8400 Ebeltoft, Denmark
[4] Maastricht Univ, Sch Business & Econ, NL-6200 MD Maastricht, Netherlands
[5] Natl Inst Hlth & Welf THL, FI-70701 Kuopio, Finland
[6] Univ Ulster, Sch Nursing, Jordanstown BT37 0QB, North Ireland
[7] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands
[8] Univ Ulster, Dept Pharm & Pharmaceut Sci, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
[9] Univ Ulster, No Ireland Ctr Food & Hlth NICHE, Coleraine BT52 1SA, Londonderry, North Ireland
[10] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands
关键词
Consumer behaviour; Risk perception; Benefit perception; GENETICALLY-MODIFIED FOOD; PROCESSING TECHNOLOGIES; PERCEIVED HEALTHINESS; SCIENTIFIC EVIDENCE; PUBLIC PERCEPTIONS; FUNCTIONAL FOODS; TASTE ATTITUDES; LOW-FAT; ACCEPTANCE; CONSUMPTION;
D O I
10.1016/j.fct.2011.06.006
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Benefit and risk perception with respect to food consumption, have been a part of human daily life from beginning of time. In today's society the food chain is long with many different types of actors and low degree of transparency. Making informed food choices where knowledge of benefits and risks is part of the decision making process are therefore complicated for consumers. Thus, to understand how consumers perceive benefits and risks of foods, their importance in relation to quality evaluations are aspects that need to be addressed. The objective of this paper is to discuss state of the art in understanding consumer perceptions of benefits and risks of foods in order to improve understanding of consumer behaviour in the food domain. Risks may be associated with both acute and long term consequences, some of which may have serious effects. Perceived risks are connected to morbidity and mortality along two dimensions relating to unknown risk, and to which extent the risk is dreaded by the consumer. Unfamiliar, uncertain, unknown, uncontrollable, and severe consequences are some factors associated with risk perception. Novel food processing techniques, for instance, score high on several of these parameters and are consequently regarded with suspicion and perceived as risky by consumers. On a daily basis, benefits of foods and food consumption are more important in most consumers' minds than risks. Benefits are often associated with food's ability to assuage hunger, and to provide pleasure through eating and socialising. In addition, two main categories of benefits that are important for acceptance of product innovations are health and environmental benefits. Benefit and risk perception of foods seem to be inversely correlated, so when something is perceived as being highly beneficial, it is correspondingly perceived as having low risk. However, slightly different paths are used in the formation of these perceptions; benefit perception is based on heuristics and experience, while risk perception is to a larger extent the result of cognitive information processing. Consumers are particularly conservative when it comes to perception and acceptance of foods compared to other products. Benefit-risk evaluations tend to be skewed towards acceptance of all that is traditional and well-known (benefits), and rejection or suspicion towards anything that is novel or highly processed (risks) regardless of actual risk. Knowledge of how consumers perceive benefits and risks of foods, may contribute to understanding benefit-risk perception in other areas related to personal, societal or environmental perspectives. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [31] Benefit-risk analysis: examples using quantitative methods
    Holden, WL
    Juhaeri, J
    Dai, WJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (08) : 693 - 697
  • [32] Benefit-risk analysis: a proposal using quantitative methods
    Holden, WL
    Juhaeri, J
    Dai, WJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (07) : 611 - 616
  • [33] Benefit-Risk Analysis for Decision-Making: An Approach
    Raju, G. K.
    Gurumurthi, K.
    Domike, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 654 - 671
  • [34] A benefit-risk analysis of rotavirus vaccination, France, 2015
    Lamrani, Adnane
    Tubert-Bitter, Pascale
    Hill, Catherine
    Escolano, Sylvie
    [J]. EUROSURVEILLANCE, 2017, 22 (50): : 28 - 37
  • [35] BENEFIT-RISK ANALYSIS IN DESIGN OF HIGHWAY STREAM CROSSINGS
    KNEPP, AJ
    TSENG, MT
    JONES, JS
    [J]. PUBLIC ROADS, 1976, 40 (02) : 66 - 69
  • [36] Quantitative Benefit-Risk Analysis of Medical Radiation Exposures
    Zanzonico, Pat
    Stabin, Michael G.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2014, 44 (03) : 210 - 214
  • [37] COSMETIC LEGISLATION - BENEFIT-RISK
    KLEINFELD, V
    [J]. JOURNAL OF THE AMERICAN MEDICAL WOMENS ASSOCIATION, 1974, 29 (07) : 306 - 309
  • [38] The Role of Spontaneous Events Databases for Benefit-Risk Analysis
    Qizilbash, Nawab
    Mendez, Ignacio
    Sanchez de la Rosa, Rainel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 114 - 114
  • [39] THE ROLE OF SPONTANEOUS EVENTS DATABASES FOR BENEFIT-RISK ANALYSIS
    Qizilbash, N.
    Mendez, I
    Sanchez-de la Rosa, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A318 - A319
  • [40] FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals
    Lackey, Leila
    Thompson, Graham
    Eggers, Sara
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 170 - 179